The ATS 2024 Clinical Trials submission site is closed.
The Clinical Trials Symposium will be programmed as a 120-minute event on Monday, May 20, 2024, from 9:15 – 11:15 a.m. We anticipate selecting up to 4 presentations. This session is a platform for important Phase III trial results but can also feature results from large Phase II trials that are novel and represent important new understandings.
Final selection of the trials for the session will be based on pre-evaluation of the key results by an International Conference Committee (ICC) sub-committee that includes the ICC Chair and Chair elect and additional ICC members with clinical trials expertise as needed.
Important Notes and Dates:
- The Clinical Trials Symposium will be recorded. Full agreement to the ATS 2024 Speakers Agreement is required for participation.
- Clinical Trials Submission Deadline: The submission site is now closed.
- Accepted trials will be published as an abstract in the conference program and the American Journal of Respiratory and Critical Care Medicine
- Notification from ATS: April 10, 2024
- Presenter name due to ATS: April 18, 2024
Any questions or concerns, please contact D'Ann Brown-Janowiak via email at djanowiak@thoracic.org.
